← All stocks

Denali Therapeutics Inc.

DNLI Net selling

CIK 0001714899 #1526 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.30M

$326.81K on a plan · $0.00 straight out of an exercise

Sold at will

$973.36K

4 of 7 sales

Net

−$1.30M

−$973.36K against sales at will

By person

14 insiders · 7 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Watts Ryan J.

President and CEO

—

$580.77K (1)

−$580.77K

2,417,217

1.51%

$53.88M

−0.9%

Schuth Alexander O.

COFO and Secretary

—

$420.60K (3)

−$420.60K

802,744

0.5022%

$17.89M

+13.9%

Thornberry Nancy

Director

—

$261.93K (2) scheduled

−$261.93K

19,686

0.0123%

$438.80K

+5.4%

Chin Peter Scott

Chief Medical Officer

—

$36.87K (1)

−$36.87K

204,538

0.1280%

$4.56M

−0.8%

BAKER BROS. ADVISORS LP entity

Director

—

3,422,366

2.14%

$76.28M

+1.0%

Tessier-Lavigne Marc

Director

—

1,886,576

1.18%

$42.05M

+0.3%

Ho Carole

Chief Medical Officer

—

216,585

0.1355%

$4.83M

+82.3%

SATO VICKI L

Director

—

107,976

0.0675%

$2.41M

−6.2%

Krognes Steve E.

Director

—

38,202

0.0239%

$851.52K

−57.1%

Klein Peter S

Director

—

33,941

0.0212%

$756.54K

+57.9%

Cook Jennifer E.

Director

—

32,483

0.0203%

$724.05K

+62.1%

FLATLEY JAY T

Director

—

22,628

0.0142%

$504.38K

+122.2%

Schenkein David P

Director

—

21,665

0.0136%

$482.91K

+0.8%

Van Hauwermeiren Timothy

Director

—

17,040

0.0107%

$379.82K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 19

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 3

Sales straight out of an exercise 0

Sales at will 4

Transactions with no price 0

Shares from compensation/vesting 237,184

History held since 8 Dec 2017